Therapeutic Cataract & Refractive
Lens Technology
Glasses
Ptosis
AMD
COVID-19
DME
Ocular Surface Disease
Optic Relief
Geographic Atrophy
Cornea
Conjunctivitis
LASIK
Myopia
Presbyopia
Allergy
Nutrition
Pediatrics
Retina
Cataract
Contact Lenses
Lid and Lash
Dry Eye
Glaucoma
Refractive Surgery
Comanagement
Blepharitis
OCT
Patient Care
Diabetic Eye Disease
Technology

Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD

Name: Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD
Uploaded: 2021-11-22T19:35:13.023Z
Description: Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients

November 22, 2021

Shane Foster, OD
Brooke Henson, Editor

Video

Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients

Shane Foster, OD discusses highlights from his American Academy of Optometry poster presentation on upper eyelid elevation in acquired ptosis patients with once-daily topical Oxymetazoline 0.1%.